The Latin America, Middle East and Africa Dystonia Drugs Market would witness market growth of 7.7% CAGR during the forecast period (2022-2028).
In its early stages, dystonia is triggered by specific motions or tasks, but it can occur at rest in its later stages. It typically affects the same group of muscles, resulting in repetitive, repetitive movements over time. Typically, the illness develops gradually, with localized symptoms indicating its presence. Blepharospasm may be characterized by eye irritation, hypersensitivity to bright light, and increased blinking. Subtle facial spasms, chewing problems, or changes in speech cadence may mark oromandibular dystonia. Indicators of limb dystonia include cramping of the hand during writing and weariness during walking or other manual activity.
Variability also exists in the course of dystonia. For some people, the disease progresses slowly, while for others, it reaches a plateau. For some individuals, dystonia stabilizes relatively gradually and no longer advances. The advanced stage is characterized by quick and involuntary rhythmic movements, twisting postures, thoracic contortions, aberrant walking, and eventually fixed postural deformities. Typically, the condition is not accompanied by pain. However, it may cause pain in affected areas. Due to deterioration of the spine, irritation of the nerve roots, or recurrent headaches, cervical dystonia can be very unpleasant. Limb dystonia may not be uncomfortable initially, but it may become severe over time. Joint deterioration caused by uncontrolled muscular contractions may lead to the onset of arthritis.
The Saudi Arabian government has a $65 billion investment plan for Vision 2030 to build out the nation's healthcare system. Additionally, it targets the privatization of 290 hospitals and 2,300 primary health facilities to raise private sector involvement from 40% to 65% by 2030. The MOH intends to establish health clusters throughout Saudi Arabia to advance integrated and preventative care and increase healthcare system access. Each set will have a connected network of medical professionals to care for about a million people. Increasing the number of globally certified hospitals, increasing the number of primary care visits per person from two to four, and raising the standard of preventative and therapeutic healthcare services are some of the other MOH goals. This supports the growth of the regional market.
The Brazil market dominated the LAMEA Dystonia Drugs Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $17 Million by 2028. The Argentina market is experiencing a CAGR of 8.2% during (2022 - 2028). Additionally, The UAE market would display a CAGR of 7.4% during (2022 - 2028).
Based on Distribution Channel, the market is segmented into Drug Stores & Retail Pharmacies, Hospital Pharmacies and Online Providers. Based on Route of Administration, the market is segmented into Oral and Injectable. Based on Type, the market is segmented into GABAergic Agents, Dopaminergic Agents, Anticonvulsants Drugs and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
Free Valuable Insights: The Global Dystonia Drugs Market is Predict to reach $1.1 Billion by 2028, at a CAGR of 5.4%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Pfizer, Inc., Novartis AG, Teva Pharmaceuticals Industries Ltd., AbbVie, Inc., F. Hoffmann-La Roche Ltd., Ipsen Pharma Biotech SAS, Hameln Pharma Gmbh (Siegfried Group, LLP), Amneal Pharmaceuticals, Inc., Merz Pharma GmbH & Co. KGaA, and Wellona Pharma.
Scope of the Study
Market Segments Covered in the Report:
By Distribution Channel
- Drug Stores & Retail Pharmacies
- Hospital Pharmacies
- Online Providers
By Route of Administration
By Type
- GABAergic Agents
- Dopaminergic Agents
- Anticonvulsants Drugs
- Others
By Country
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Key Market Players
List of Companies Profiled in the Report:
- Pfizer, Inc.
- Novartis AG
- Teva Pharmaceuticals Industries Ltd.
- AbbVie, Inc.
- F.Hoffmann-La Roche Ltd.
- Ipsen Pharma Biotech SAS
- Hameln Pharma Gmbh (Siegfried Group, LLP)
- Amneal Pharmaceuticals, Inc.
- Merz Pharma GmbH & Co. KGaA
- Wellona Pharma
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Dystonia Drugs Market, by Distribution Channel
1.4.2 LAMEA Dystonia Drugs Market, by Route of Administration
1.4.3 LAMEA Dystonia Drugs Market, by Type
1.4.4 LAMEA Dystonia Drugs Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market composition & scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. LAMEA Dystonia Drugs Market by Distribution Channel
3.1 LAMEA Drug Stores & Retail Pharmacies Market by Country
3.2 LAMEA Hospital Pharmacies Market by Country
3.3 LAMEA Online Providers Market by Country
Chapter 4. LAMEA Dystonia Drugs Market by Route of Administration
4.1 LAMEA Oral Market by Country
4.2 LAMEA Injectable Market by Country
Chapter 5. LAMEA Dystonia Drugs Market by Type
5.1 LAMEA GABAergic Agents Market by Country
5.2 LAMEA Dopaminergic Agents Market by Country
5.3 LAMEA Anticonvulsants Drugs Market by Country
5.4 LAMEA Others Market by Country
Chapter 6. LAMEA Dystonia Drugs Market by Country
6.1 Brazil Dystonia Drugs Market
6.1.1 Brazil Dystonia Drugs Market by Distribution Channel
6.1.2 Brazil Dystonia Drugs Market by Route of Administration
6.1.3 Brazil Dystonia Drugs Market by Type
6.2 Argentina Dystonia Drugs Market
6.2.1 Argentina Dystonia Drugs Market by Distribution Channel
6.2.2 Argentina Dystonia Drugs Market by Route of Administration
6.2.3 Argentina Dystonia Drugs Market by Type
6.3 UAE Dystonia Drugs Market
6.3.1 UAE Dystonia Drugs Market by Distribution Channel
6.3.2 UAE Dystonia Drugs Market by Route of Administration
6.3.3 UAE Dystonia Drugs Market by Type
6.4 Saudi Arabia Dystonia Drugs Market
6.4.1 Saudi Arabia Dystonia Drugs Market by Distribution Channel
6.4.2 Saudi Arabia Dystonia Drugs Market by Route of Administration
6.4.3 Saudi Arabia Dystonia Drugs Market by Type
6.5 South Africa Dystonia Drugs Market
6.5.1 South Africa Dystonia Drugs Market by Distribution Channel
6.5.2 South Africa Dystonia Drugs Market by Route of Administration
6.5.3 South Africa Dystonia Drugs Market by Type
6.6 Nigeria Dystonia Drugs Market
6.6.1 Nigeria Dystonia Drugs Market by Distribution Channel
6.6.2 Nigeria Dystonia Drugs Market by Route of Administration
6.6.3 Nigeria Dystonia Drugs Market by Type
6.7 Rest of LAMEA Dystonia Drugs Market
6.7.1 Rest of LAMEA Dystonia Drugs Market by Distribution Channel
6.7.2 Rest of LAMEA Dystonia Drugs Market by Route of Administration
6.7.3 Rest of LAMEA Dystonia Drugs Market by Type
Chapter 7. Company Profiles
7.1 Pfizer, Inc.
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Regional & Segmental Analysis
7.1.4 Research & Development Expense
7.2 Novartis AG
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental and Regional Analysis
7.2.4 Research & Development Expense
7.3 Teva Pharmaceutical Industries Ltd.
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Regional Analysis
7.3.4 Research & Development Expenses
7.3.5 Recent strategies and developments:
7.3.5.1 Product Launches and Product Expansions:
7.4 AbbVie, Inc.
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Regional Analysis
7.4.4 Research & Development Expense
7.5 F. Hoffmann-La Roche Ltd.
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Segmental and Regional Analysis
7.5.4 Research & Development Expense
7.6 Ipsen Pharma Biotech SAS
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Segmental and Regional Analysis
7.6.4 Research & Development Expense
7.7 Hameln Pharma Gmbh (Siegfried Group, LLP)
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Research & Development Expenses
7.8 Amneal Pharmaceuticals, Inc.
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Segmental Analysis
7.8.4 Research & Development Expenses
7.9 Merz Pharma GmbH & Co. KGaA
7.9.1 Company Overview
7.9.2 Recent strategies and developments:
7.9.2.1 Approvals and Trials:
7.10. Wellona Pharma
7.10.1 Company Overview
TABLE 1 LAMEA Dystonia Drugs Market, 2018 - 2021, USD Million
TABLE 2 LAMEA Dystonia Drugs Market, 2022 - 2028, USD Million
TABLE 3 LAMEA Dystonia Drugs Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 4 LAMEA Dystonia Drugs Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 5 LAMEA Drug Stores & Retail Pharmacies Market by Country, 2018 - 2021, USD Million
TABLE 6 LAMEA Drug Stores & Retail Pharmacies Market by Country, 2022 - 2028, USD Million
TABLE 7 LAMEA Hospital Pharmacies Market by Country, 2018 - 2021, USD Million
TABLE 8 LAMEA Hospital Pharmacies Market by Country, 2022 - 2028, USD Million
TABLE 9 LAMEA Online Providers Market by Country, 2018 - 2021, USD Million
TABLE 10 LAMEA Online Providers Market by Country, 2022 - 2028, USD Million
TABLE 11 LAMEA Dystonia Drugs Market by Route of Administration, 2018 - 2021, USD Million
TABLE 12 LAMEA Dystonia Drugs Market by Route of Administration, 2022 - 2028, USD Million
TABLE 13 LAMEA Oral Market by Country, 2018 - 2021, USD Million
TABLE 14 LAMEA Oral Market by Country, 2022 - 2028, USD Million
TABLE 15 LAMEA Injectable Market by Country, 2018 - 2021, USD Million
TABLE 16 LAMEA Injectable Market by Country, 2022 - 2028, USD Million
TABLE 17 LAMEA Dystonia Drugs Market by Type, 2018 - 2021, USD Million
TABLE 18 LAMEA Dystonia Drugs Market by Type, 2022 - 2028, USD Million
TABLE 19 LAMEA GABAergic Agents Market by Country, 2018 - 2021, USD Million
TABLE 20 LAMEA GABAergic Agents Market by Country, 2022 - 2028, USD Million
TABLE 21 LAMEA Dopaminergic Agents Market by Country, 2018 - 2021, USD Million
TABLE 22 LAMEA Dopaminergic Agents Market by Country, 2022 - 2028, USD Million
TABLE 23 LAMEA Anticonvulsants Drugs Market by Country, 2018 - 2021, USD Million
TABLE 24 LAMEA Anticonvulsants Drugs Market by Country, 2022 - 2028, USD Million
TABLE 25 LAMEA Others Market by Country, 2018 - 2021, USD Million
TABLE 26 LAMEA Others Market by Country, 2022 - 2028, USD Million
TABLE 27 LAMEA Dystonia Drugs Market by Country, 2018 - 2021, USD Million
TABLE 28 LAMEA Dystonia Drugs Market by Country, 2022 - 2028, USD Million
TABLE 29 Brazil Dystonia Drugs Market, 2018 - 2021, USD Million
TABLE 30 Brazil Dystonia Drugs Market, 2022 - 2028, USD Million
TABLE 31 Brazil Dystonia Drugs Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 32 Brazil Dystonia Drugs Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 33 Brazil Dystonia Drugs Market by Route of Administration, 2018 - 2021, USD Million
TABLE 34 Brazil Dystonia Drugs Market by Route of Administration, 2022 - 2028, USD Million
TABLE 35 Brazil Dystonia Drugs Market by Type, 2018 - 2021, USD Million
TABLE 36 Brazil Dystonia Drugs Market by Type, 2022 - 2028, USD Million
TABLE 37 Argentina Dystonia Drugs Market, 2018 - 2021, USD Million
TABLE 38 Argentina Dystonia Drugs Market, 2022 - 2028, USD Million
TABLE 39 Argentina Dystonia Drugs Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 40 Argentina Dystonia Drugs Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 41 Argentina Dystonia Drugs Market by Route of Administration, 2018 - 2021, USD Million
TABLE 42 Argentina Dystonia Drugs Market by Route of Administration, 2022 - 2028, USD Million
TABLE 43 Argentina Dystonia Drugs Market by Type, 2018 - 2021, USD Million
TABLE 44 Argentina Dystonia Drugs Market by Type, 2022 - 2028, USD Million
TABLE 45 UAE Dystonia Drugs Market, 2018 - 2021, USD Million
TABLE 46 UAE Dystonia Drugs Market, 2022 - 2028, USD Million
TABLE 47 UAE Dystonia Drugs Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 48 UAE Dystonia Drugs Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 49 UAE Dystonia Drugs Market by Route of Administration, 2018 - 2021, USD Million
TABLE 50 UAE Dystonia Drugs Market by Route of Administration, 2022 - 2028, USD Million
TABLE 51 UAE Dystonia Drugs Market by Type, 2018 - 2021, USD Million
TABLE 52 UAE Dystonia Drugs Market by Type, 2022 - 2028, USD Million
TABLE 53 Saudi Arabia Dystonia Drugs Market, 2018 - 2021, USD Million
TABLE 54 Saudi Arabia Dystonia Drugs Market, 2022 - 2028, USD Million
TABLE 55 Saudi Arabia Dystonia Drugs Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 56 Saudi Arabia Dystonia Drugs Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 57 Saudi Arabia Dystonia Drugs Market by Route of Administration, 2018 - 2021, USD Million
TABLE 58 Saudi Arabia Dystonia Drugs Market by Route of Administration, 2022 - 2028, USD Million
TABLE 59 Saudi Arabia Dystonia Drugs Market by Type, 2018 - 2021, USD Million
TABLE 60 Saudi Arabia Dystonia Drugs Market by Type, 2022 - 2028, USD Million
TABLE 61 South Africa Dystonia Drugs Market, 2018 - 2021, USD Million
TABLE 62 South Africa Dystonia Drugs Market, 2022 - 2028, USD Million
TABLE 63 South Africa Dystonia Drugs Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 64 South Africa Dystonia Drugs Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 65 South Africa Dystonia Drugs Market by Route of Administration, 2018 - 2021, USD Million
TABLE 66 South Africa Dystonia Drugs Market by Route of Administration, 2022 - 2028, USD Million
TABLE 67 South Africa Dystonia Drugs Market by Type, 2018 - 2021, USD Million
TABLE 68 South Africa Dystonia Drugs Market by Type, 2022 - 2028, USD Million
TABLE 69 Nigeria Dystonia Drugs Market, 2018 - 2021, USD Million
TABLE 70 Nigeria Dystonia Drugs Market, 2022 - 2028, USD Million
TABLE 71 Nigeria Dystonia Drugs Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 72 Nigeria Dystonia Drugs Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 73 Nigeria Dystonia Drugs Market by Route of Administration, 2018 - 2021, USD Million
TABLE 74 Nigeria Dystonia Drugs Market by Route of Administration, 2022 - 2028, USD Million
TABLE 75 Nigeria Dystonia Drugs Market by Type, 2018 - 2021, USD Million
TABLE 76 Nigeria Dystonia Drugs Market by Type, 2022 - 2028, USD Million
TABLE 77 Rest of LAMEA Dystonia Drugs Market, 2018 - 2021, USD Million
TABLE 78 Rest of LAMEA Dystonia Drugs Market, 2022 - 2028, USD Million
TABLE 79 Rest of LAMEA Dystonia Drugs Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 80 Rest of LAMEA Dystonia Drugs Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 81 Rest of LAMEA Dystonia Drugs Market by Route of Administration, 2018 - 2021, USD Million
TABLE 82 Rest of LAMEA Dystonia Drugs Market by Route of Administration, 2022 - 2028, USD Million
TABLE 83 Rest of LAMEA Dystonia Drugs Market by Type, 2018 - 2021, USD Million
TABLE 84 Rest of LAMEA Dystonia Drugs Market by Type, 2022 - 2028, USD Million
TABLE 85 Key Information – Pfizer, Inc.
TABLE 86 Key Information – Novartis AG
TABLE 87 Key Information – Teva Pharmaceuticals Industries Ltd.
TABLE 88 Key information – AbbVie, Inc.
TABLE 89 KEY INFORMATION – F. Hoffmann-La Roche Ltd.
TABLE 90 Key Information – Ipsen Pharma Biotech SAS
TABLE 91 Key Information – Hameln Pharma Gmbh
TABLE 92 Key Information – Amneal Pharmaceuticals, INc.
TABLE 93 Key information – Merz Pharma GmbH & Co. KGaA
TABLE 94 Key Information – Wellona Pharma
List of Figures
FIG 1 Methodology for the research